RXR-induced TNF-α suppression is reversed by morphine in activated U937 cells

Abstract

Deficiency in vitamin A has been associated with adverse clinical outcomes1 in drug users with HIV-1 infection. Retinoids have been demonstrated to suppress proinflammatory cytokine production by immune cells in vitro. These effects are induced by ligand-mediated activation of the retinoid receptors—retinoic acid receptor (RAR) and retinoid X receptor (RXR). In these studies, the effects of all- trans-retinoid acid (ATRA, a RAR agonist), 9- cis-retinoic acid (9cis RA; RAR and RXR agonist), LG101305 (RXR agonist), LG100815 (RAR antagonist) and LG101208 (RXR antagonist) on TNF-α production by phytohemagglutanin-activated U937 cells and the modulation of these effects by morphine were examined. TNF-α production was suppressed in all cultures exposed to retinoid agonist and antagonist agents. For cells exposed to RXR agonists or RAR antagonist, incubation with morphine resulted in the reversal of TNF-α suppression and this effect was inhibited by naloxone. These data suggest that interactions between RXR and morphine are involved in the immune effects of retinoids on TNF-α production by activated U937 cells. Such information may be important for understanding interactions between drugs of abuse and immune function in individuals with chronic proinflammatory states such as HIV-1 infection.